{
    "title": "113_s2126",
    "content": "Regenerative Medicine Promotion Act of 2014 - Requires the Comptroller General to submit to Congress a report identifying all ongoing federal programs and activities regarding regenerative medicine. Directs the Secretary of Health and Human Services (HHS) to establish a Regenerative Medicine Coordinating Council, which shall: prepare a national strategy to support research into regenerative medicine and enable the development of drugs, biological products, medical devices, and biomaterials for use in regenerative medicine, develop national goals for regenerative medicine research and product development, prepare a plan specifying priorities for research into regenerative medicine. Identify sources of funding for research into regenerative medicine and areas where such funding is inadequate or duplicative. Make recommendations regarding federal policies to support development and marketing of regenerative medicine products. Develop consensus standards regarding scientific issues critical to regulator approval of regenerative medicine products. And determine the need for establishing centers of excellence or consortia to further advance regenerative medicine. Directs the Council to: (1) adopt procedures to ensure the receipt of public input. And (2) submit an annual report on its activities to Congress, the Director of the National Institutes of Health (NIH), and the Commissioner of Food and Drugs (FDA)."
}